Skip to main content
JA Clinical Reports
Fig. 1 | JA Clinical Reports

Fig. 1

From: Lusutrombopag (Mulpleta®) treatment in a patient with thrombocytopenia complicated by cirrhosis prior to continuous epidural anesthesia during renal artery embolization: a case report

Fig. 1

Clinical course. From day 1 to day 5, the patient was treated with 3 mg of lusutrombopag daily. Treatment was discontinued on day 5 due to an increase in platelet count (7.4 × 104/μL). Platelet count on day 11 was 12.6 × 104/μL, and epidural anesthesia was performed the following day. Platelet count remained at 9.0 × 104/μL during hospitalization (from day 11 to day 19)

Back to article page